Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients

Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients

The biology of plasma cell dyscrasias (PCD) involves both genetic and immune-related factors. Since genetic lesions are necessary but not sufficient for Multiple Myeloma (MM) evolution, several authors hypothesized that immune dysfunction involving both B and T cell counterparts plays a key role in...

Full description

Bibliographic Details
Main Authors: Gregorio Barilà, Laura Pavan, Susanna Vedovato, Tamara Berno, Mariella Lo Schirico, Massimiliano Arangio Febbo, Antonella Teramo, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Anna Fregnani, Sabrina Manni, Valentina Trimarco, Samuela Carraro, Monica Facco, Francesco Piazza, Gianpietro Semenzato, Renato Zambello
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
immunophenotyping
treatment
lenalidomide
ASCT-autologous stem cell transplantation
cytotoxic response
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.682658/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.682658/full

Similar Items